MEDICLIN AG/ DE0006595101 /
| 2024-11-15 5:36:23 PM | Chg. 0.000 | Volume | Bid2024-11-15 | Ask2024-11-15 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2.640EUR | 0.00% | 2,775 Turnover: 7,159.520 |
-Bid Size: - | -Ask Size: - | 118.75 mill.EUR | - | - |
Assets
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 158.6000 | 155.5000 | 161.2000 | 161.6000 | 177.5000 | ||||||
| Intangible Assets | 1.6000 | 2 | 1.9000 | 3.6000 | 6.1000 | ||||||
| Long-Term Investments | 2.1000 | 1.5000 | 1.4000 | 1.2000 | .9000 | ||||||
| Fixed Assets | 221.1000 | 216.8000 | 217.4000 | 219.3000 | 239.8000 | ||||||
| Inventories | 6.5000 | 6.4000 | 6.2000 | 6.3000 | 7.3000 | ||||||
| Accounts Receivable | 61.4000 | 62 | 67.3000 | 71.1000 | 84 | ||||||
| Cash and Cash Equivalents | 13.2000 | 26.3000 | 29.5000 | 41.6000 | 26.9000 | ||||||
| Current Assets | 91.7000 | 102.8000 | 112 | 127.7000 | 128.9000 | ||||||
| Total Assets | 312.9000 | 319.6000 | 329.4000 | 347.1000 | 368.6000 | ||||||
Liabilities
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 18.2000 | 13 | 12 | 13 | 13.7000 | ||||||
| Long-term debt | 60.5000 | 54.1000 | 47.4000 | 45.5000 | 37.9000 | ||||||
| Liabilities to Banks | 67.6000 | 61.2000 | 65.9000 | 65.2000 | 62.4000 | ||||||
| Provisions | 53.2000 | 64.5000 | 65 | 69 | 86.6000 | ||||||
| Liabilities | 160.7000 | 165.7000 | 160.3000 | 165.5000 | 183.4000 | ||||||
| Share Capital | 47.5000 | 47.5000 | 47.5000 | 47.5000 | 47.5000 | ||||||
| Total Equity | 152.2000 | 153.9000 | 169.1000 | 181.6000 | 185.3000 | ||||||
| Minority Interests | -.2000 | -.4000 | -.3000 | -.3000 | -.3000 | ||||||
| Total liabilities equity | 312.9000 | 319.6000 | 329.4000 | 347.1000 | 368.6000 | ||||||
Income Statement
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 515 | 538 | 555.3000 | 580.3000 | 609.1000 | ||||||
| Depreciation (total) | 17.5000 | 18.5000 | 18.4000 | 19.2000 | 20.4000 | ||||||
| Operating Result | 2.1000 | 15.6000 | 23.6000 | 24 | 6.6000 | ||||||
| Interest Income | -4.7000 | -3.8600 | -3.6100 | -3.1000 | -2.4000 | ||||||
| Income Before Taxes | -2.6000 | 11.7000 | 20 | 20.9000 | 4.3000 | ||||||
| Income Taxes | .2000 | 3.3000 | 3.4000 | 4.3000 | .3000 | ||||||
| Minority Interests Profit | .1000 | .1000 | -.0600 | -.0600 | -.0500 | ||||||
| Net Income | -2.6000 | 8.5000 | 16.5000 | 16.5000 | 3.9000 | ||||||
Per Share
Cash Flow
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 10 | 32.1000 | 28.9000 | 29.9000 | 19.3000 | ||||||
| Cash Flow from Investing Activities | -11.5000 | -12.5000 | -19 | -17.9000 | -31 | ||||||
| Cash Flow from Financing | -8.2000 | -6.5000 | -6.7000 | .1000 | -3.1000 | ||||||
| Decrease / Increase in Cash | -9.7000 | 13.1000 | 3.2000 | 12.1000 | -14.7000 | ||||||
| Employees | 6,372 | 6,432 | 6,524 | 6,649 | 6,964 | ||||||
